Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Mar 15, 2023; 15(3): 464-489
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.464
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.464
Figure 1 Effects of Xiaojianzhong decoction on body weight, gastric mucosal pathological conditions and liver kidney toxicity in N-methyl-N’-nitro-N-nitrosoguanidine-induced gastric precancerous lesions rats.
A: Schematic diagram of model construction and treatment; B: Schematic diagram of weight change in rats; C: Representative images of hematoxylin-eosin and alcian blue-periodic acid-Schiff staining of gastric tissues; D-G: Ki-67 and caudal-type homeobox protein 2 (CDX-2) expression was determined using immunohistochemistry (n = 5); Ki-67 and CDX-2 positive score was determined using Image J; H: Superoxide dismutase and malondialdehyde levels in serum (n = 3); I: Alanine aminotransferase and creatinine levels in serum (n = 3). Data are expressed as mean ± SD. aP < 0.05, bP < 0.01, cP < 0.001 vs control group; dP < 0.05, eP < 0.01, fP < 0.001 vs model group. XJZ-L: Low dose of Xiaojianzhong decoction; XJZ-M: Middle dose of Xiaojianzhong decoction; XJZ-H: High dose of Xiaojianzhong decoction; SOD: Superoxide dismutase; MDA: Malondialdehyde; ALT: Alanine aminotransferase; Cr: Creatinine.
- Citation: Zhang JX, Bao SC, Chen J, Chen T, Wei HL, Zhou XY, Li JT, Yan SG. Xiaojianzhong decoction prevents gastric precancerous lesions in rats by inhibiting autophagy and glycolysis in gastric mucosal cells. World J Gastrointest Oncol 2023; 15(3): 464-489
- URL: https://www.wjgnet.com/1948-5204/full/v15/i3/464.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i3.464